Vergleich

MYO6 [MUD-19]

ArtNr 20-272-190369
Hersteller GENWAY
Menge 0.05 ml
Kategorie
Typ Antibody
Applikationen WB, ELISA
Clon MUD-19
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-1A9C55
Similar products 20-272-190369
Lieferbar
Genway ID:
GWB-1A9C55
Clone:
MUD-19
Isotype:
IgG1
Immunogen:
Synthetic peptide corresponding to amino acids 291-302 of Human MYO6.
Antigen Species:
Human
Positive Control:
A431 whole cell lysate
Target:
MYO6
Localization:
Cell Membrane Cytoplasmic and Golgi Apparatus
Concentration:
1 mg/ml Storage
Preservative:
15% Sodium Azide; Constituents: 1% BSA 0. 01M PBS. pH 7. 4
Application Note:
ELISA: Use at an assay dependent concentration. WB: Use at a concentration of 2 µ g/ml. Detects a band of approximately 150 kDa. Not tested in other applications. Optimal dilutions/concentrations should be determined by the end user. Cellular
Localization:
Cell Membrane Cytoplasmic and Golgi Apparatus Myosins belong to a superfamily of actin based motor proteins comprising at least 15 or more classes. There are two main groups of myosins: the conventional (class II) and the unconventional myosins. Myosin VI is a relatively abundant widespread unconventional myosin composed of an N-terminal motor domain a light chain binding neck region a coil-coiled region and a highly conserved C-terminal domain. At the converter region between the catalytic head and the neck region of myosin VI there is a characteristic linker of approximately 50 amino acids. Native myosin VI is apparently a two-headed dimer of the heavy chains with each heavy chain bound to calmodulin light chain. Myosin VI is a unique reverse actin motor in vitro i. e. to display motility towards the pointed (minus) ends of actin filaments a direction opposite to all other currently known myosins.
Function:
Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Myosin 6 is a reverse-direction motor protein that moves towards the minus-end of actin filaments. Has slow rate of actin-activated ADP release due to weak ATP binding. Functions in a variety of intracellular processes such as vesicular membrane trafficking and cell migration. Required for the structural integrity of the Golgi apparatus via the p53-dependent pro-survival pathway. Appears to be involved in a very early step of clathrin-mediated endocytosis in polarized epithelial cells. May act as a regulator of F-actin dynamics. May play a role in transporting DAB2 from the plasma membrane to specific cellular targets. Required for structural integrity of inner ear hair cells (By similarity).
Subunit:
Homodimer. Binding to calmodulin through a unique insert not found in other myosins located in the neck region between the motor domain and the IQ domain appears to contribute to the directionality reversal. This interaction occurs only if the C-terminal lobe of calmodulin is occupied by calcium. Interaction with F-actin/ACTN1 occurs only at the apical brush border domain of the proximal tubule cells (By similarity). Interacts with DAB2. In vitro the C-terminal globular tail binds a C-terminal region of DAB2. Interacts with CFTR. Forms a complex with CFTR and DAB2 in the apical membrane of epithelial cells.
Subcellular Location:
Golgi apparatus trans-Golgi network membrane; Peripheral membrane protein. Nucleus. Cytoplasm perinuclear region. Membrane clathrin-coated pit. Cell projection ruffle membrane; Peripheral membrane protein. Note=Also present in endocyctic vesicles and membrane ruffles. Translocates from membrane ruffles endocytic vesicles and cytoplasm to Golgi apparatus perinuclear membrane and nucleus through induction by p53 and p53-induced DNA damage. Recruited into membrane ruffles from cell surface by EGF-stimulation. Colocalizes with DAB2 in clathrin-coated pits/vesicles.
Subcellular Location:
Isoform 3: Cytoplasmic vesicle clathrin-coated vesicle membrane.
Subcellular Location:
Isoform 4: Cytoplasmic vesicle clathrin-coated vesicle membrane. Cell projection ruffle membrane.
Tissue Specificity:
Expressed in most tissues examined including heart brain placenta pancreas spleen thymus prostate testis ovary small intestine and colon. Highest levels in brain pancreas testis and small intestine. Also expressed in fetal brain and cochlea. Isoform 1 and isoform 2 containing the small insert and isoform 4 containing neither insert are expressed in unpolarized epithelial cells.
Domain:
Divided into three regions: a N-terminal motor (head) domain followed by a neck domain consisting of a calmodulin-binding linker domain and a single IQ motif and a C-terminal tail region with a coiled-coil and a unique globular domain required for interaction with other proteins.
Ptm:
Phosphorylation in the motor domain induced by EGF results in translocation of MYO6 from the cell surface to membrane ruffles and affects F-actin dynamics. Phosphorylated in vitro by p21-activated kinase (PAK) (By similarity).
Disease:
Defects in MYO6 are the cause of non-syndromic sensorineural deafness autosomal dominant type 22 (DFNA22) [MIM:606346]. DFNA22 is a form of sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear the nerve pathways to the brain or the area of the brain that receives sound information. DFNA22 is progressive and postlingual with onset during childhood. By the age of approximately 50 years affected individuals invariably have profound sensorineural deafness.
Disease:
Defects in MYO6 are the cause of non-syndromic sensorineural deafness autosomal recessive type 37 (DFNB37) [MIM:607821].
Disease:
Defects in MYO6 are the cause of sensorineural deafness with hypertrophic cardiomyopathy (DFNHCM) [MIM:606346].
Similarity:
Contains 1 IQ domain.
Similarity:
Contains 1 myosin head-like domain.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 0.05 ml
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen